The Dana-Farber Cancer Institute is the third high-tech cancer clinic in the United States. As part of a collaborative study with the Harvard Cancer Center, the Dana-Farber Cancer Institute was founded in 1947 by Dr Ph, the father of modern chemotherapy. Established Sidney Farber. To train future clinical and scientific leaders in cancer treatment, the institute focuses on both empathetic patient treatment and facilitating an understanding of the underlying causes of cancer. The Dana-Farber / Boston Children’s Cancer and Blood Disorders Center was sponsored by the United States. The News & World Report has also nominated the country’s second-largest childhood cancer program. The Institute’s current research areas include lung cancer, breast cancer, skin cancer, stem cell transplantation, and clinical cancer through specific innovative projects incorporating advanced technology in the form of human antibody engineering platforms and lung cancer gene modifications. Includes research.